Varian Medical Systems
SALT LAKE CITY, November 15, 2011 - Booth - A78/Hall 10 -- Varian Medical Systems, Inc.
SKANE, Sweden, October 28, 2011 - - Lund University Hospital Replaces Incumbent Equipment and Software with Advanced Varian Systems in Mission to Reduce Waiting Times Varian Medical Systems (NYSE: VAR) has been awarded a contract to supply four TrueBeam™ treatment systems to Lund University Hospital in Sweden, one of the country's largest radiotherapy departments.
MIAMI BEACH, Florida, October 6, 2011 - - Results of a multi-institutional phase II RTOG 0631 trial summarized in presentation at the 2011 Annual Meeting of the American Society for Radiation Oncology (ASTRO) Image-guided stereotactic radiosurgery (SRS) can be an effective and feasible approach for treating up to three spinal metastases, according to an international team of researchers reporting on the results of a recently concluded multi-institutional phase II trial.
MIAMI, October 5, 2011 - - Results of a phase II study summarized in presentation at the 2011 Annual Meeting of the American Society for Radiation Oncology (ASTRO) Early results from a prospective Phase II trial presented today at the American Society of Radiation Oncology 53rd annual meeting show that patients with low-risk prostate cancer who were treated with radiosurgery using treatment technologies from Varian Medical Systems (NYSE: VAR) and Calypso Medical Systems had favorable health-related quality of life scores and minimal toxicities.
MIAMI, October 4, 2011 - - Study of potentially operable Stage I NSCLC demonstrates tumor control comparable to surgery Results of new research presented at the American Society of Radiation Oncology (ASTRO) 53rd Annual Meeting this week showed that patients with different types of early stage non-small cell lung cancer (NSCLC) can benefit from treatment with stereotactic body radiosurgery (SBRT).